← 產業報告目錄
Cobamamide for Injection Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 117報告編號 APO-4ae0ba53a0
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Cobamamide for Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cobamamide for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cobamamide for Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Cobamamide for Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cobamamide for Injection include Chongqing Yaoyou Pharmaceutical, Jiuquan Dadeli pharmaceutical, Jiangsu Jiuxu Pharmaceutical, North China Pharmaceutical Group, Hebei Zhitong Biopharmaceutical, Hainan Star Pharmaceutical and Haerbin Medisan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cobamamide for Injection market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cobamamide for Injection Market by Company
Chongqing Yaoyou Pharmaceutical
Jiuquan Dadeli pharmaceutical
Jiangsu Jiuxu Pharmaceutical
North China Pharmaceutical Group
Hebei Zhitong Biopharmaceutical
Hainan Star Pharmaceutical
Haerbin Medisan
Cobamamide for Injection Segment by Type
0.5mg
1.5mg
1.0mg
Cobamamide for Injection Segment by Application
Hospital
Drug Store
Other
Cobamamide for Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobamamide for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cobamamide for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobamamide for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cobamamide for Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cobamamide for Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cobamamide for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Cobamamide for Injection Market Size (2021-2032)
2.2.2 Global Cobamamide for Injection Sales (2021-2032)
2.2.3 Global Cobamamide for Injection Market Average Price (2021-2032)
2.3 Cobamamide for Injection by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 0.5mg
2.3.3 1.5mg
2.3.4 1.0mg
2.4 Cobamamide for Injection by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Hospital
2.4.3 Drug Store
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Cobamamide for Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Cobamamide for Injection Sales (Kg) of Manufacturers (2021-2026)
3.3 Global Cobamamide for Injection Revenue of Manufacturers (2021-2026)
3.4 Global Cobamamide for Injection Average Price by Manufacturers (2021-2026)
3.5 Global Cobamamide for Injection Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Cobamamide for Injection, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Cobamamide for Injection, Product Type & Application
3.8 Global Manufacturers of Cobamamide for Injection, Established Date
3.9 Global Cobamamide for Injection Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Chongqing Yaoyou Pharmaceutical
4.1.1 Chongqing Yaoyou Pharmaceutical Company Information
4.1.2 Chongqing Yaoyou Pharmaceutical Business Overview
4.1.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio
4.1.5 Chongqing Yaoyou Pharmaceutical Recent Developments
4.2 Jiuquan Dadeli pharmaceutical
4.2.1 Jiuquan Dadeli pharmaceutical Company Information
4.2.2 Jiuquan Dadeli pharmaceutical Business Overview
4.2.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio
4.2.5 Jiuquan Dadeli pharmaceutical Recent Developments
4.3 Jiangsu Jiuxu Pharmaceutical
4.3.1 Jiangsu Jiuxu Pharmaceutical Company Information
4.3.2 Jiangsu Jiuxu Pharmaceutical Business Overview
4.3.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio
4.3.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
4.4 North China Pharmaceutical Group
4.4.1 North China Pharmaceutical Group Company Information
4.4.2 North China Pharmaceutical Group Business Overview
4.4.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.4.4 North China Pharmaceutical Group Cobamamide for Injection Product Portfolio
4.4.5 North China Pharmaceutical Group Recent Developments
4.5 Hebei Zhitong Biopharmaceutical
4.5.1 Hebei Zhitong Biopharmaceutical Company Information
4.5.2 Hebei Zhitong Biopharmaceutical Business Overview
4.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio
4.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
4.6 Hainan Star Pharmaceutical
4.6.1 Hainan Star Pharmaceutical Company Information
4.6.2 Hainan Star Pharmaceutical Business Overview
4.6.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio
4.6.5 Hainan Star Pharmaceutical Recent Developments
4.7 Haerbin Medisan
4.7.1 Haerbin Medisan Company Information
4.7.2 Haerbin Medisan Business Overview
4.7.3 Haerbin Medisan Cobamamide for Injection Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Haerbin Medisan Cobamamide for Injection Product Portfolio
4.7.5 Haerbin Medisan Recent Developments
5 Global Cobamamide for Injection Market Scenario by Region
5.1 Global Cobamamide for Injection Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Cobamamide for Injection Sales by Region: 2021-2032
5.2.1 Global Cobamamide for Injection Sales by Region: 2021-2026
5.2.2 Global Cobamamide for Injection Sales by Region: 2027-2032
5.3 Global Cobamamide for Injection Revenue by Region: 2021-2032
5.3.1 Global Cobamamide for Injection Revenue by Region: 2021-2026
5.3.2 Global Cobamamide for Injection Revenue by Region: 2027-2032
5.4 North America Cobamamide for Injection Market Facts & Figures by Country
5.4.1 North America Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Cobamamide for Injection Sales by Country (2021-2032)
5.4.3 North America Cobamamide for Injection Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Cobamamide for Injection Market Facts & Figures by Country
5.5.1 Europe Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Cobamamide for Injection Sales by Country (2021-2032)
5.5.3 Europe Cobamamide for Injection Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Cobamamide for Injection Market Facts & Figures by Country
5.6.1 Asia Pacific Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Cobamamide for Injection Sales by Country (2021-2032)
5.6.3 Asia Pacific Cobamamide for Injection Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Cobamamide for Injection Market Facts & Figures by Country
5.7.1 South America Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Cobamamide for Injection Sales by Country (2021-2032)
5.7.3 South America Cobamamide for Injection Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Cobamamide for Injection Market Facts & Figures by Country
5.8.1 Middle East and Africa Cobamamide for Injection Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Cobamamide for Injection Sales by Country (2021-2032)
5.8.3 Middle East and Africa Cobamamide for Injection Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Cobamamide for Injection Sales by Type (2021-2032)
6.1.1 Global Cobamamide for Injection Sales by Type (2021-2032) & (Kg)
6.1.2 Global Cobamamide for Injection Sales Market Share by Type (2021-2032)
6.2 Global Cobamamide for Injection Revenue by Type (2021-2032)
6.2.1 Global Cobamamide for Injection Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Cobamamide for Injection Revenue Market Share by Type (2021-2032)
6.3 Global Cobamamide for Injection Price by Type (2021-2032)
7 Segment by Application
7.1 Global Cobamamide for Injection Sales by Application (2021-2032)
7.1.1 Global Cobamamide for Injection Sales by Application (2021-2032) & (Kg)
7.1.2 Global Cobamamide for Injection Sales Market Share by Application (2021-2032)
7.2 Global Cobamamide for Injection Revenue by Application (2021-2032)
7.2.1 Global Cobamamide for Injection Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Cobamamide for Injection Revenue Market Share by Application (2021-2032)
7.3 Global Cobamamide for Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Cobamamide for Injection Value Chain Analysis
8.1.1 Cobamamide for Injection Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Cobamamide for Injection Production Mode & Process
8.2 Cobamamide for Injection Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Cobamamide for Injection Distributors
8.2.3 Cobamamide for Injection Customers
9 Global Cobamamide for Injection Analyzing Market Dynamics
9.1 Cobamamide for Injection Industry Trends
9.2 Cobamamide for Injection Industry Drivers
9.3 Cobamamide for Injection Industry Opportunities and Challenges
9.4 Cobamamide for Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Cobamamide for Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Cobamamide for Injection Sales (Kg) of Manufacturers (2021-2026)
Table 7. Global Cobamamide for Injection Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Cobamamide for Injection Revenue of Manufacturers (2021-2026)
Table 9. Global Cobamamide for Injection Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Cobamamide for Injection Average Price (US$/g) of Manufacturers (2021-2026)
Table 11. Global Cobamamide for Injection Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Cobamamide for Injection, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Cobamamide for Injection, Product Type & Application
Table 14. Global Cobamamide for Injection Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Cobamamide for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Chongqing Yaoyou Pharmaceutical Company Information
Table 19. Chongqing Yaoyou Pharmaceutical Business Overview
Table 20. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 21. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Portfolio
Table 22. Chongqing Yaoyou Pharmaceutical Recent Developments
Table 23. Jiuquan Dadeli pharmaceutical Company Information
Table 24. Jiuquan Dadeli pharmaceutical Business Overview
Table 25. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 26. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Portfolio
Table 27. Jiuquan Dadeli pharmaceutical Recent Developments
Table 28. Jiangsu Jiuxu Pharmaceutical Company Information
Table 29. Jiangsu Jiuxu Pharmaceutical Business Overview
Table 30. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 31. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Portfolio
Table 32. Jiangsu Jiuxu Pharmaceutical Recent Developments
Table 33. North China Pharmaceutical Group Company Information
Table 34. North China Pharmaceutical Group Business Overview
Table 35. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 36. North China Pharmaceutical Group Cobamamide for Injection Product Portfolio
Table 37. North China Pharmaceutical Group Recent Developments
Table 38. Hebei Zhitong Biopharmaceutical Company Information
Table 39. Hebei Zhitong Biopharmaceutical Business Overview
Table 40. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 41. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Portfolio
Table 42. Hebei Zhitong Biopharmaceutical Recent Developments
Table 43. Hainan Star Pharmaceutical Company Information
Table 44. Hainan Star Pharmaceutical Business Overview
Table 45. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 46. Hainan Star Pharmaceutical Cobamamide for Injection Product Portfolio
Table 47. Hainan Star Pharmaceutical Recent Developments
Table 48. Haerbin Medisan Company Information
Table 49. Haerbin Medisan Business Overview
Table 50. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 51. Haerbin Medisan Cobamamide for Injection Product Portfolio
Table 52. Haerbin Medisan Recent Developments
Table 53. Global Cobamamide for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 54. Global Cobamamide for Injection Sales by Region (2021-2026) & (Kg)
Table 55. Global Cobamamide for Injection Sales Market Share by Region (2021-2026)
Table 56. Global Cobamamide for Injection Sales by Region (2027-2032) & (Kg)
Table 57. Global Cobamamide for Injection Sales Market Share by Region (2027-2032)
Table 58. Global Cobamamide for Injection Revenue by Region (2021-2026) & (US$ Million)
Table 59. Global Cobamamide for Injection Revenue Market Share by Region (2021-2026)
Table 60. Global Cobamamide for Injection Revenue by Region (2027-2032) & (US$ Million)
Table 61. Global Cobamamide for Injection Revenue Market Share by Region (2027-2032)
Table 62. North America Cobamamide for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 63. North America Cobamamide for Injection Sales by Country (2021-2026) & (Kg)
Table 64. North America Cobamamide for Injection Sales by Country (2027-2032) & (Kg)
Table 65. North America Cobamamide for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 66. North America Cobamamide for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 67. Europe Cobamamide for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 68. Europe Cobamamide for Injection Sales by Country (2021-2026) & (Kg)
Table 69. Europe Cobamamide for Injection Sales by Country (2027-2032) & (Kg)
Table 70. Europe Cobamamide for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 71. Europe Cobamamide for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 72. Asia Pacific Cobamamide for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 73. Asia Pacific Cobamamide for Injection Sales by Country (2021-2026) & (Kg)
Table 74. Asia Pacific Cobamamide for Injection Sales by Country (2027-2032) & (Kg)
Table 75. Asia Pacific Cobamamide for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 76. Asia Pacific Cobamamide for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 77. South America Cobamamide for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. South America Cobamamide for Injection Sales by Country (2021-2026) & (Kg)
Table 79. South America Cobamamide for Injection Sales by Country (2027-2032) & (Kg)
Table 80. South America Cobamamide for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 81. South America Cobamamide for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 82. Middle East and Africa Cobamamide for Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. Middle East and Africa Cobamamide for Injection Sales by Country (2021-2026) & (Kg)
Table 84. Middle East and Africa Cobamamide for Injection Sales by Country (2027-2032) & (Kg)
Table 85. Middle East and Africa Cobamamide for Injection Revenue by Country (2021-2026) & (US$ Million)
Table 86. Middle East and Africa Cobamamide for Injection Revenue by Country (2027-2032) & (US$ Million)
Table 87. Global Cobamamide for Injection Sales by Type (2021-2026) & (Kg)
Table 88. Global Cobamamide for Injection Sales by Type (2027-2032) & (Kg)
Table 89. Global Cobamamide for Injection Sales Market Share by Type (2021-2026)
Table 90. Global Cobamamide for Injection Sales Market Share by Type (2027-2032)
Table 91. Global Cobamamide for Injection Revenue by Type (2021-2026) & (US$ Million)
Table 92. Global Cobamamide for Injection Revenue by Type (2027-2032) & (US$ Million)
Table 93. Global Cobamamide for Injection Revenue Market Share by Type (2021-2026)
Table 94. Global Cobamamide for Injection Revenue Market Share by Type (2027-2032)
Table 95. Global Cobamamide for Injection Price by Type (2021-2026) & (US$/g)
Table 96. Global Cobamamide for Injection Price by Type (2027-2032) & (US$/g)
Table 97. Global Cobamamide for Injection Sales by Application (2021-2026) & (Kg)
Table 98. Global Cobamamide for Injection Sales by Application (2027-2032) & (Kg)
Table 99. Global Cobamamide for Injection Sales Market Share by Application (2021-2026)
Table 100. Global Cobamamide for Injection Sales Market Share by Application (2027-2032)
Table 101. Global Cobamamide for Injection Revenue by Application (2021-2026) & (US$ Million)
Table 102. Global Cobamamide for Injection Revenue by Application (2027-2032) & (US$ Million)
Table 103. Global Cobamamide for Injection Revenue Market Share by Application (2021-2026)
Table 104. Global Cobamamide for Injection Revenue Market Share by Application (2027-2032)
Table 105. Global Cobamamide for Injection Price by Application (2021-2026) & (US$/g)
Table 106. Global Cobamamide for Injection Price by Application (2027-2032) & (US$/g)
Table 107. Key Raw Materials
Table 108. Raw Materials Key Suppliers
Table 109. Cobamamide for Injection Distributors List
Table 110. Cobamamide for Injection Customers List
Table 111. Cobamamide for Injection Industry Trends
Table 112. Cobamamide for Injection Industry Drivers
Table 113. Cobamamide for Injection Industry Restraints
Table 114. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Cobamamide for Injection Product Image
Figure 5. Global Cobamamide for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Cobamamide for Injection Market Size (2021-2032) & (US$ Million)
Figure 7. Global Cobamamide for Injection Sales (2021-2032) & (Kg)
Figure 8. Global Cobamamide for Injection Average Price (US$/g) & (2021-2032)
Figure 9. 0.5mg Product Image
Figure 10. 1.5mg Product Image
Figure 11. 1.0mg Product Image
Figure 12. Hospital Product Image
Figure 13. Drug Store Product Image
Figure 14. Other Product Image
Figure 15. Global Cobamamide for Injection Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Cobamamide for Injection, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Cobamamide for Injection Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Cobamamide for Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Cobamamide for Injection Sales by Region in 2025
Figure 21. Global Cobamamide for Injection Revenue by Region in 2025
Figure 22. North America Cobamamide for Injection Market Size by Country in 2025
Figure 23. North America Cobamamide for Injection Sales Market Share by Country (2021-2032)
Figure 24. North America Cobamamide for Injection Revenue Market Share by Country (2021-2032)
Figure 25. United States Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Cobamamide for Injection Market Size by Country in 2025
Figure 28. Europe Cobamamide for Injection Sales Market Share by Country (2021-2032)
Figure 29. Europe Cobamamide for Injection Revenue Market Share by Country (2021-2032)
Figure 30. Germany Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Netherlands Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Cobamamide for Injection Market Size by Country in 2025
Figure 36. Asia Pacific Cobamamide for Injection Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Cobamamide for Injection Revenue Market Share by Country (2021-2032)
Figure 38. China Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Cobamamide for Injection Market Size by Country in 2025
Figure 47. South America Cobamamide for Injection Sales Market Share by Country (2021-2032)
Figure 48. South America Cobamamide for Injection Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Cobamamide for Injection Market Size by Country in 2025
Figure 53. Middle East and Africa Cobamamide for Injection Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Cobamamide for Injection Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Cobamamide for Injection Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Cobamamide for Injection Sales Market Share by Type (2021-2032)
Figure 59. Global Cobamamide for Injection Revenue Market Share by Type (2021-2032)
Figure 60. Global Cobamamide for Injection Price (US$/g) by Type (2021-2032)
Figure 61. Global Cobamamide for Injection Sales Market Share by Application (2021-2032)
Figure 62. Global Cobamamide for Injection Revenue Market Share by Application (2021-2032)
Figure 63. Global Cobamamide for Injection Price (US$/g) by Application (2021-2032)
Figure 64. Cobamamide for Injection Value Chain
Figure 65. Cobamamide for Injection Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Cobamamide for Injection Industry Opportunities and Challenges
提及公司
Chongqing Yaoyou PharmaceuticalJiuquan Dadeli pharmaceuticalJiangsu Jiuxu PharmaceuticalNorth China Pharmaceutical GroupHebei Zhitong BiopharmaceuticalHainan Star PharmaceuticalHaerbin Medisan
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們